Julian Gangolli

Julian S. Gangolli. Mr. Gangolli is President, North America of GW Pharmaceuticals, spearheading the buildout of the company's U.S. commercial infrastructure in advance of the potential launch of its lead therapeutic candidate, Epidiolex® (cannabidiol or CBD), which is in late-stage development for diverse indications.